Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Crossover Experiments01:16

Crossover Experiments

Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Bioequivalence: Overview01:16

Bioequivalence: Overview

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SPIRIT 2025 statement: updated guideline for protocols of randomised trials.

Lancet (London, England)·2026
Same author

Highlighting Rigor, Reproducibility, and Transparency of Research in an Academic CV.

Clinical and translational science·2026
Same author

A scoping study of the whole-cell imaging literature as a foundation for the emerging field of cell anatomy.

BMC biology·2026
Same author

Key takeaways from Stanford's symposium on AI for Data Science.

Journal of clinical and translational science·2025
Same author

Registration and reporting of clinical trials affiliated with California universities and with primary completion date from 2014 to 2017.

Trials·2025
Same author

Remembering Drummond Rennie-Champion of Integrity in Science and Scientific Publication.

JAMA·2025
Same journal

Diminished Returns: The Hidden Health Costs of Upward Social Mobility for Black Americans.

Annual review of public health·2026
Same journal

The Epidemiology, Prevention, and Control of Type 2 Diabetes in Low- and Middle-Income Countries.

Annual review of public health·2026
Same journal

Community-Based Participatory Research: Evolution and Significant Developments.

Annual review of public health·2026
Same journal

Causal Inference in Health Disparities Research.

Annual review of public health·2026
Same journal

The Health Implications of Fatherhood: A Comprehensive Literature Review.

Annual review of public health·2026
Same journal

Practice-Focused Research Based on Public Health Critical Race Praxis.

Annual review of public health·2026
See all related articles

Related Experiment Video

Updated: May 26, 2026

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

The methods of comparative effectiveness research.

Harold C Sox1, Steven N Goodman

  • 1Department of Medicine, The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth Medical School, Hanover, New Hampshire 03755, USA. hsox@comcast.net

Annual Review of Public Health
|January 10, 2012
PubMed
Summary
This summary is machine-generated.

Comparative Effectiveness Research (CER) methods enhance medical decisions for policy and individuals. CER focuses on real-world patient data and active treatment comparisons to tailor care effectively.

More Related Videos

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Related Experiment Videos

Last Updated: May 26, 2026

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

  • Health Services Research
  • Medical Decision Making
  • Evidence-Based Practice

Background:

  • Comparative Effectiveness Research (CER) is crucial for improving healthcare decisions.
  • CER aims to inform both policy and individual patient care strategies.
  • Current medical practice generates vast amounts of real-world data.

Purpose of the Study:

  • To review and describe the methodologies employed in Comparative Effectiveness Research (CER).
  • To highlight the core principles of CER, including head-to-head treatment comparisons and real-world patient populations.
  • To emphasize the importance of tailoring medical evidence to individual patient characteristics.

Main Methods:

  • Discusses observational research, randomized trials, and decision analysis as principal CER methods.
  • Highlights the particular challenges and vulnerabilities of using observational data in CER.
  • Explores strategies for extracting actionable insights from routine clinical practice data.

Main Results:

  • CER methods are essential for improving medical care decisions at policy and individual levels.
  • Key elements include active treatment comparisons, typical patient populations, and personalized care evidence.
  • Observational studies are critical but require careful methodology due to reflecting usual practice.

Conclusions:

  • CER methodologies are vital for advancing evidence-based medicine and patient-centered care.
  • The field challenges researchers to maximize the utility of real-world clinical data.
  • CER methods are broadly applicable and beneficial to public health research systems.